首页 | 本学科首页   官方微博 | 高级检索  
     

仙灵骨葆胶囊联合甲氨蝶呤治疗类风湿关节炎继发骨质疏松症有效性的系统评价
引用本文:郑子恢,李琼,李文英,张白歌,马琳,赵紫楠. 仙灵骨葆胶囊联合甲氨蝶呤治疗类风湿关节炎继发骨质疏松症有效性的系统评价[J]. 中国医院用药评价与分析, 2021, 0(3): 329-332,337
作者姓名:郑子恢  李琼  李文英  张白歌  马琳  赵紫楠
作者单位:北京医院药学部
摘    要:目的:系统评价仙灵骨葆胶囊联合甲氨蝶呤治疗类风湿关节炎(rheumatoid arthritis,RA)继发骨质疏松症(osteoporosis,OP)的有效性,为中药治疗该病提供参考依据.方法:检索the Cochrane Library、PubMed、EMBase、中国知网、万方数据库、中国生物医学文献数据库和维普...

关 键 词:仙灵骨葆胶囊  甲氨蝶呤  类风湿关节炎  骨质疏松症  Meta分析  随机对照试验

Systematic Review of Efficacy of Xianling Gubao Capsules Combined with Methorexatein the Treatment of Rheumatoid Arthritis with Osteoporisis
ZHENG Zihui,LI Qiong,LI Wenying,ZHANG Baige,MA Lin,ZHAO Zinan. Systematic Review of Efficacy of Xianling Gubao Capsules Combined with Methorexatein the Treatment of Rheumatoid Arthritis with Osteoporisis[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2021, 0(3): 329-332,337
Authors:ZHENG Zihui  LI Qiong  LI Wenying  ZHANG Baige  MA Lin  ZHAO Zinan
Affiliation:(Dept.of Pharmaceutical Science,Beijing Hospital,NationalCenter of Gerontology,Chinese Academy of Medical Sciences,Instituteof Geriatric Medicine,Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application(Beijing Hospital),Beijing 100730,China)
Abstract:OBJECTIVE:To systematically evaluate the efficacy of Xianling Gubao capsules combined with methorexatein the treatment of rheumatoid arthritis(RA)with osteoporisis(OP),so as to provide reference for the treatment of the disease with traditional Chinese medicine.METHODS:The Cochrane Library,PubMed,EMBase,CNKI,Wanfang database,CBM and VIP database were retrieved to collect the randomized controlled trial(RCT)of Xianling Gubao capsules combined with methorexatein(study group)vs.methotrexate alone(control group)the treatment of RA with OP.The retrieval time was from the establishment of the database to Oct.2020.According to the inclusion and exclusion criteria,literature were screened,data were extracted,and the methodological quality of the included literature was evaluated.Rev Man 5.4 software was used for Meta-analysis.RESULTS:A total of 4 literature that met the criteria were included,with a total of 270 cases,including 135 cases in the study group and 135 cases in the control group.Significant efficiency,total effective rate,bone mineral density(BMD),morning stiffness time and joint function index were evaluated.Meta-analysis showed that two groups the differences of significant efficiency(RR=1.59,95%CI=1.16-2.20,P=0.005),total effective rate(RR=1.29,95%CI=1.13-1.48,P=0.0003),BMD of femoral neck(MD=0.03,95%CI=0.02-0.04,P<0.00001),morning stiffness time(MD=-6.17,95%CI=-7.72--4.63,P<0.00001)and joint function index(MD=-0.33,95%CI=-0.39--0.27,P<0.00001)and other aspects were statistically significant,the above indexes in the study group were significantly better than those in the control group.There was no significant difference in BMD of lumbar spine between two groups(MD=0.05,95%CI=-0.00-0.10,P=0.06>0.05).CONCLUSIONS:Xianling Gubao capsules can effectively increase the significant efficiency and total effective rate of methotrexate in the treatment of RA with OP,and improve the BMD of femoral neck,morning stiffness time and joint function index.
Keywords:Xianling Gubao capsules  Methorexate  Rheumatoid arthritis  Osteoporisis  Meta-analysis  Randomized controlled trial
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号